| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/21/2010 | US7855076 Use of discoidin domain receptor 1 (DDR1) and agents that affect the DDR1/collagen pathway |
| 12/21/2010 | US7855058 Human cyclin-dependent kinase (hPNQALRE) |
| 12/21/2010 | US7855056 Antibody against tumor specific antigen as target |
| 12/21/2010 | US7855050 determining the GPVI allelotype of subjects in need of surgery, with a low platelet count, with an acquired bleeding disorder, on blood thinning drugs, or of blood donors; diagnosis of an increased risk of bleeding |
| 12/21/2010 | US7854942 Anti-gluten egg yolk antibodies for the treatment of celiac disease |
| 12/21/2010 | US7854937 Flavivirus fusion inhibitors |
| 12/21/2010 | US7854931 Immunizing compostion and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein |
| 12/21/2010 | US7854930 Anti-igf-ir antibodies and uses thereof |
| 12/21/2010 | CA2538725C Nogo-a binding molecules and pharmaceutical use thereof |
| 12/21/2010 | CA2528114C Monoclonal antibodies specific for buprenorphine and metabolites thereof |
| 12/21/2010 | CA2490724C Method for the diagnosis and prognosis of malignant diseases |
| 12/21/2010 | CA2457145C Assay method for alzheimer's disease |
| 12/21/2010 | CA2329138C Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| 12/21/2010 | CA2307316C Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies |
| 12/21/2010 | CA2267069C Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy |
| 12/21/2010 | CA2220753C Novel peptides and compositions which modulate apoptosis |
| 12/21/2010 | CA2199821C Cloning and regulation of an endothelial cell protein c/activated protein c receptor |
| 12/21/2010 | CA2161351C Transgenic non-human animals capable of producing heterologous antibodies |
| 12/16/2010 | WO2010143713A1 Novel protein and gene that codes therefor |
| 12/16/2010 | WO2010143606A1 Novel site-specific recombination enzyme and site-specific recombination method using sequence capable of recognizing the enzyme |
| 12/16/2010 | WO2010142990A1 ANTI-EpCAM ANTIBODIES |
| 12/16/2010 | WO2010142952A2 Antibodies |
| 12/16/2010 | WO2010142551A2 Single variable domain (vhh) antibodies to cytokines of the il-17 receptor family |
| 12/16/2010 | WO2010142534A1 Biparatopic protein constructs directed against il-23 |
| 12/16/2010 | WO2010142423A2 Use of an anti-tau ps422 antibody for the treatment of brain diseases |
| 12/16/2010 | WO2010141986A1 Novel antibodies and uses therefor |
| 12/16/2010 | WO2010099955A8 Protease for wound conditioning and skin care |
| 12/16/2010 | WO2010096470A3 Method for inhibiting neurodegeneration |
| 12/16/2010 | WO2010093214A3 Monoclonal antibody recognizing scye1 and use thereof |
| 12/16/2010 | WO2010089411A3 Pd-1 antibodies and pd-l1 antibodies and uses thereof |
| 12/16/2010 | WO2010010467A3 Neutralizing anti-influenza a virus antibodies and uses thereof |
| 12/16/2010 | US20100317837 Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries |
| 12/16/2010 | US20100317836 Novel biological substance nesfatin and its related substances and uses thereof |
| 12/16/2010 | US20100317835 Anti-Adam-15 Antibodies and Utilization of the Same |
| 12/16/2010 | US20100317834 IgG Immunoglobulin Variants with Optimized Effector Function |
| 12/16/2010 | US20100317826 Neoplasm specific antibodies and uses thereof |
| 12/16/2010 | US20100317540 Methods for producing members of specific binding pairs |
| 12/16/2010 | US20100317096 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 12/16/2010 | US20100317083 Methods and kits for dissociating fcgamma-receptor-igg complexes and for igg purification and detection |
| 12/16/2010 | US20100317054 PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF |
| 12/16/2010 | US20100317034 Primate t-lymphotropic viruses |
| 12/16/2010 | US20100317026 VMP-Like Sequences Of Pathogenic Borrelia |
| 12/16/2010 | US20100317013 Methods and compositions for detecting spermatozoa or semen in a sample |
| 12/16/2010 | US20100317011 Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use |
| 12/16/2010 | US20100317003 Novel compositions and methods in cancer with altered expression of kcnj9 |
| 12/16/2010 | US20100316994 Diagnosis and therapy of cancer using sgp28-related molecules |
| 12/16/2010 | US20100316661 HIV-1 Envelope Glycoprotein Oligomer and Methods of Use |
| 12/16/2010 | US20100316656 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use |
| 12/16/2010 | US20100316654 Neutralizing antibodies to influenza viruses |
| 12/16/2010 | US20100316653 Compositions and methods for diagnosis and treatment of orthopoxviruses |
| 12/16/2010 | US20100316652 Vascular endothelial cell growth factor antagonists |
| 12/16/2010 | US20100316648 Novel plasminogen receptor, polypeptides and antibodies thereof |
| 12/16/2010 | US20100316646 Compositions and methods for modulating immune responses |
| 12/16/2010 | US20100316645 Bispecific Antigen Binding Proteins |
| 12/16/2010 | US20100316641 Engineered antibody constant domain molecules |
| 12/16/2010 | US20100316637 Compositions and Methods for Diagnosing and Treating Cancer |
| 12/16/2010 | US20100316635 Kit for diagnosis of breast cancer using herceptin, a composition comprising herceptin and a method for detecting herceptin-sensitive her2 overexpressed cell using the same |
| 12/16/2010 | US20100316634 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 12/16/2010 | US20100316633 Inhibition of angiogenesis |
| 12/16/2010 | US20100316631 Water Soluble Curcumin-Based Compounds |
| 12/16/2010 | US20100316630 Anti-idiotype antibodies of the human monoclonal antibody sc-1, and their production and use |
| 12/16/2010 | US20100316627 Human antibodies to human IL-6 receptor |
| 12/16/2010 | US20100316602 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 12/16/2010 | US20100316574 Oncofetal Antigen/Immature Laminin Receptor Peptides for the Sensitization of Dendritic Cells for Cancer Therapy |
| 12/16/2010 | US20100316568 Diagnostic agent and therapeutic agent for pancreatic cancer |
| 12/16/2010 | US20100316564 Immunological targeting of pathological tau proteins |
| 12/16/2010 | US20100316563 Method For The Preparation Of New Oligoclonal Antibodies |
| 12/16/2010 | CA2765237A1 Novel protein and gene that codes therefor |
| 12/16/2010 | CA2762594A1 Use of an anti-tau ps422 antibody for the treatment of brain diseases |
| 12/15/2010 | EP2261671A2 Diagnostic assay for human Matrix-Gla-Protein and its use as a biomarker |
| 12/15/2010 | EP2261667A2 Nucleic acid molecules and proteins for the identification, assessment, prevention, and their therapy of ovarian cancer |
| 12/15/2010 | EP2261666A1 Method for detection of pneumococcus |
| 12/15/2010 | EP2261380A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins |
| 12/15/2010 | EP2261378A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins |
| 12/15/2010 | EP2261377A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins |
| 12/15/2010 | EP2261376A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins |
| 12/15/2010 | EP2261375A2 Method of Preventing Virus:Cell Fusion By Inhibiting the Function of the Fusion Initiation Region in RNA Viruses Having Class I Membrane Fusogenic Envelope Proteins |
| 12/15/2010 | EP2261374A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class i membrane fusogenic envelope proteins |
| 12/15/2010 | EP2261357A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261356A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261355A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261354A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261353A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261352A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261351A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261350A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261349A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261348A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261347A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261346A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261345A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261344A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261343A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261342A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261341A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261340A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261339A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261338A2 Neisseria meningitidis antigens and compositions |
| 12/15/2010 | EP2261335A1 Compositions and methods for increasing bone mineralisation |
| 12/15/2010 | EP2261260A2 Methods for inducing autolysis in infectious bacteria |